These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12435162)
1. Evidence supporting the benefit of early intervention in rheumatoid arthritis. Emery P J Rheumatol Suppl; 2002 Nov; 66():3-8. PubMed ID: 12435162 [TBL] [Abstract][Full Text] [Related]
2. Progression in early rheumatoid arthritis. Combe B Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046 [TBL] [Abstract][Full Text] [Related]
3. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis. Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365 [TBL] [Abstract][Full Text] [Related]
4. Key randomized trials of single agents in early rheumatoid arthritis. van de Putte LB J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164 [TBL] [Abstract][Full Text] [Related]
5. Early rheumatoid arthritis -- is there a window of opportunity? Cush JJ J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies in rheumatoid arthritis over a 40-year period. Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment. Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of rheumatoid arthritis. Rindfleisch JA; Muller D Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies in early rheumatoid arthritis. Smolen JS; Aletaha D; Machold KP Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis: principles of early treatment. Bresnihan B J Rheumatol Suppl; 2002 Nov; 66():9-12. PubMed ID: 12435163 [TBL] [Abstract][Full Text] [Related]
12. Disease remission the goal of therapy in rheumatoid arthritis. Nisar MK; Ostör AJ Practitioner; 2010 Dec; 254(1735):17-21, 2. PubMed ID: 21306034 [TBL] [Abstract][Full Text] [Related]
13. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Sesin CA; Bingham CO Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes? Dougados M; Smolen JS J Rheumatol Suppl; 2002 Nov; 66():20-6. PubMed ID: 12435165 [TBL] [Abstract][Full Text] [Related]
15. Established rheumatoid arthritis: clinical assessments. van Riel PL; Fransen J Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029 [TBL] [Abstract][Full Text] [Related]
16. Management of early rheumatoid arthritis. Suresh E J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697 [TBL] [Abstract][Full Text] [Related]
17. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Nell VP; Machold KP; Eberl G; Stamm TA; Uffmann M; Smolen JS Rheumatology (Oxford); 2004 Jul; 43(7):906-14. PubMed ID: 15113999 [TBL] [Abstract][Full Text] [Related]
18. Innovative treatment strategies for patients with rheumatoid arthritis. van der Kooij SM; Allaart CF; Dijkmans BA; Breedveld FC Curr Opin Rheumatol; 2008 May; 20(3):287-94. PubMed ID: 18388520 [TBL] [Abstract][Full Text] [Related]
19. Early rheumatoid arthritis. Scott DL Br Med Bull; 2007; 81-82():97-114. PubMed ID: 17540693 [TBL] [Abstract][Full Text] [Related]
20. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]